Glucose variability patterns for precision nutrition in diabetes
The GLUCOTYPES project aims to identify early glycaemic patterns and their dietary influences using advanced technologies to develop precision nutrition strategies for Type 2 diabetes prevention and management.
Projectdetails
Introduction
Type 2 diabetes (T2D) has emerged as a global epidemic, impacting 1 in 10 people worldwide and causing over 114,000 deaths annually in Europe. Despite extensive research, understanding the pathogenic mechanisms driving distinct disease subtypes and how diet influences glucose homeostasis has remained elusive.
Knowledge Gap
This knowledge gap leaves individuals with or at high risk of T2D without effective prevention or control strategies, urging a paradigm shift in our approach.
Project Overview
The GLUCOTYPES project brings together leading experts in various fields from five European countries to tackle this challenge. The areas of expertise include:
- Nutrition
- Metabolic diseases
- Glycobiology
- Gut microbiome
- Epidemiology
- Machine learning
Strategy
Our strategy capitalizes on advancements in wearable technologies, molecular biology, and bioinformatics. We propose to leverage high-temporal continuous glucose monitor data to identify patterns of early glycaemic alterations, a concept we refer to as glucotypes, which forms the core hypothesis of our research program.
Methodology
Circulating and adipose tissue glycoproteomics profiling will be used to gain molecular insights into glucotypes. Machine learning algorithms will be applied to investigate the intersection between diet and glucotypes on clinical outcomes. This will help us gain mechanistic insights into how diet and gut microbiome influence glucose homeostasis in specific glucotypes.
Clinical Study
The knowledge derived from these activities will inform a proof-of-concept precision nutrition clinical study to test the efficacy of a precision-based diet on cardiometabolic outcomes. Additionally, we aim to identify markers of beneficial responses to diet.
Conclusion
In doing so, GLUCOTYPES will come closer to understanding the divergent mechanisms that influence early glycaemic alterations and how specific diets could ameliorate these alterations. Our work will establish a foundational yet comprehensive scientific groundwork to inform future precision diabetes nutrition strategies to prevent and improve the lives of all people affected by the disease.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.988.206 |
Totale projectbegroting | € 3.988.206 |
Tijdlijn
Startdatum | 1-10-2024 |
Einddatum | 30-9-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- KOBENHAVNS UNIVERSITETpenvoerder
- WEIZMANN INSTITUTE OF SCIENCE
- UNIVERSITEIT MAASTRICHT
- UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
- ACADEMISCH ZIEKENHUIS LEIDEN
- INTERNATIONAL LIFE SCIENCES INSTITUTE EUROPEAN BRANCH AISBL
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Linking Intestinal Bacteria and Host Metabolism to Tackle Type 2 Diabetes with Novel FoodDiBaN aims to develop advanced platforms for testing novel insect-based foods to prevent intestinal dysbiosis and Type 2 diabetes, integrating AI for personalized nutritional interventions. | EIC Pathfinder | € 3.999.222 | 2024 | Details |
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout PreventionThis project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses. | EIC Pathfinder | € 3.765.840 | 2024 | Details |
Precision Nutrition to optimize immune response for metabolic healthNUTRIMMUNE investigates the impact of precision nutrition on immune responses in obesity-related NCDs, aiming to establish dietary recommendations through multi-omics analysis and intervention studies. | EIC Pathfinder | € 4.318.432 | 2024 | Details |
Linking Intestinal Bacteria and Host Metabolism to Tackle Type 2 Diabetes with Novel Food
DiBaN aims to develop advanced platforms for testing novel insect-based foods to prevent intestinal dysbiosis and Type 2 diabetes, integrating AI for personalized nutritional interventions.
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention
This project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses.
Precision Nutrition to optimize immune response for metabolic health
NUTRIMMUNE investigates the impact of precision nutrition on immune responses in obesity-related NCDs, aiming to establish dietary recommendations through multi-omics analysis and intervention studies.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
GenomeDia: a personalized medicine tool for diabetesThe project aims to develop a genetic interpretation tool to subcategorize young diabetes patients, enhancing treatment by leveraging findings from whole genome sequencing. | ERC Proof of... | € 150.000 | 2024 | Details |
Pharmacoepigenetics for precision medicine in type 2 diabetesPROCEED aims to develop and commercialize blood-based epigenetic markers to predict metformin response in Type 2 diabetes patients, enhancing personalized therapy and clinical decision-making. | ERC Proof of... | € 150.000 | 2023 | Details |
Altered brain-periphery crosstalk as a key pathomechanism for high-risk phenotypes in humansThis project aims to elucidate the role of altered brain-periphery communication in identifying high-risk diabetes phenotypes to enhance prevention and treatment strategies. | ERC Consolid... | € 1.999.838 | 2024 | Details |
Listening to Silence: The First Blood Test for Risk of Individuals at Prophylactic Time Windows to Develop Type 2 Diabetes MellitusThis project aims to develop a clinical test using novel epigenetic biomarkers to predict Type 2 Diabetes risk in non-diabetic individuals, enabling early preventive treatments. | ERC Proof of... | € 150.000 | 2024 | Details |
Circadian Control of Systemic Metabolism in Physiology and Type 2 DiabetesThis project aims to uncover how synchronizing energetic stressors with circadian rhythms can improve metabolism and inform new treatments for type 2 diabetes. | ERC Advanced... | € 2.500.000 | 2024 | Details |
GenomeDia: a personalized medicine tool for diabetes
The project aims to develop a genetic interpretation tool to subcategorize young diabetes patients, enhancing treatment by leveraging findings from whole genome sequencing.
Pharmacoepigenetics for precision medicine in type 2 diabetes
PROCEED aims to develop and commercialize blood-based epigenetic markers to predict metformin response in Type 2 diabetes patients, enhancing personalized therapy and clinical decision-making.
Altered brain-periphery crosstalk as a key pathomechanism for high-risk phenotypes in humans
This project aims to elucidate the role of altered brain-periphery communication in identifying high-risk diabetes phenotypes to enhance prevention and treatment strategies.
Listening to Silence: The First Blood Test for Risk of Individuals at Prophylactic Time Windows to Develop Type 2 Diabetes Mellitus
This project aims to develop a clinical test using novel epigenetic biomarkers to predict Type 2 Diabetes risk in non-diabetic individuals, enabling early preventive treatments.
Circadian Control of Systemic Metabolism in Physiology and Type 2 Diabetes
This project aims to uncover how synchronizing energetic stressors with circadian rhythms can improve metabolism and inform new treatments for type 2 diabetes.